EMD Serono, Inc.
9 drugs in NADAC|0 Generic,9 Brand
View Recalls (2)EMD Serono, Inc. lists 9 NDCs in the CMS NADAC file (0 generic, 9 brand), at an average NADAC of $1430.03 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
9
0G / 9B
Avg Price / Unit
$1430.0343
$306.06 – $1873.34
Avg 7d Change
-0.07%
Across 1 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does EMD Serono, Inc. make?
EMD Serono, Inc. lists 9 NDCs in the CMS NADAC file — 0 generic and 9 brand products.
What is the average price of EMD Serono, Inc. drugs?
The average NADAC across EMD Serono, Inc.'s portfolio is $1430.0343 per unit, ranging from $306.0574 to $1873.3445.
What types of drugs does EMD Serono, Inc. make?
EMD Serono, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Gonadotropin (4), Interferon beta (3).
Has EMD Serono, Inc. had any drug recalls?
2 FDA recalls are matched to EMD Serono, Inc. in the openFDA feed, most recently on Jun 29, 2020.
How has EMD Serono, Inc.'s pricing changed recently?
Over the past 7 days, 0 EMD Serono, Inc. products rose and 1 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GONAL-F RFF REDI-JECT 900 UNIT PEN FOLLITROPIN | $1873.3445 per ML | — |
GONAL-F RFF REDI-JECT 300 UNITS PEN FOLLITROPIN | $1866.5467 per ML | — |
REBIF 44 MCG/0.5 ML SYRINGE interferon beta-1a | $1849.8837 per ML | — |
REBIF REBIDOSE 44 MCG/0.5 ML INTERFERON BETA-1A | $1848.6728 per ML | — |
GONAL-F RFF REDI-JECT 450 UNIT PEN FOLLITROPIN | $1846.9120 per ML | — |
REBIF 22 MCG/0.5 ML SYRINGE INTERFERON BETA-1A | $1400.9343 per ML | — |
GONAL-F 450 UNITS VIAL follitropin alfa | $1392.3720 per EA | — |
OVIDREL 250 MCG/0.5 ML SYRG choriogonadotropin alfa | $485.5850 per ML | -0.07% |
CETROTIDE 0.25 MG VIAL cetrorelix acetate | $306.0574 per EA | — |
FDA Recalls (2)
Recalls matched by company name. Verify current status with FDA.
Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1
Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.